Abstract
SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.
Abstract
Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease
affecting about 0.5 to 1% of the population and leading to disability if left untreated.
Challenges with the currently used drugs, especially toxicity and limited clinical
efficacy, along with complications like disorders of the heart and respiratory system,
carpal tunnel syndrome, Sjögren’s syndrome, tendon rupture, cervical myelopathy,
pleuritic, pericarditis, scleritis, vasculitis, and sexual dysfunction limit its usage. Thus,
finding new therapeutic targets and the development of new drugs is the need of the
hour. This will be aided by studying different contributing factors for disease
development and progression, as well as elucidation of RA pathogenesis.
Autoantibodies in response to cells' own antigens play a regulatory role in various
autoimmune diseases like heumatoid arthritis. Some autoantibodies like rheumatoid
factor (RF) and anti citrullinated protein antibody (ACPA) are also used as serological
markers for RA diagnosis apart from their role in disease prognosis. In this chapter, the
latest insights regarding the regulatory role of immune cell-mediated antibodies in
rheumatoid arthritis are addressed.
Keywords:
Anti Citrullinated Protein Antibody (ACPA), Autoantibodies, Rheumatoid Arthritis, Rheumatoid Factor (RF), Serological markers.
Recommended Chapters
We recommend
Favorable 70-S: Investigation Branching 
Authors:Bentham Science Books